Note: ITIN applicant: Enter your individual name as it was entered on your Form W-7 application, line 1a. This should also be the same as the name you entered on the Form 1040/1040A/1040EZ you filed with your application. Use Form W-7, Application for IRS Individual Taxpayer Identification Number, to apply for an ITIN, or Form SS-4, Application for Employer Identification Number, to apply for an EIN.

In some instances, a single exposure to a strong stress cracking agent may cause premature failure, yet in others it may appear to have no effect after numerous applications. For treatment groups, a 0.5" (13 mm) square pre-soaked gauze pad containing the disinfectant/cleaner of choice was applied to the center portion of the test specimen, replacing the gauze pad every 24 hours for a total of 72 hours (3 applications). The Trilliant HC8910 and HC8920 materials were apparently unaffected by the application of Virex® TB and demonstrated nearly 100% retention of tensile properties relative to the strain control group.

Wall thickness should be as thin as possible for the application. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

 * Yes If ‘yes’, exact statement of the intent that is included in the facility’s TRA Plan to reduce the creation of the toxic substance at the facility: ** DEHA is a plasticizer and is created in our Orangeville Plasticizer plant (small quantities) and used as reactant in the formulation compound in our Orangeville compound site.   * For on­site use/processing Summarize why the toxic substance is used at the facility: ** DEHA is produced to be used for compound formulation. Materials or feedstock substitution Product design or reformulation Equipment or process modifications Spill or leak prevention On­site reuse, recycling or recovery Improved inventory management or purchasing techniques Good operator practice or training About us News Contact us Stay connected HEALTH healthycanadians.gc.ca TRAVEL travel.gc.ca SERVICE CANADA servicecanada.gc.ca JOBS jobbank.gc.ca ECONOMY actionplan.gc.ca Canada.gc.ca Terms and Conditions Transparency Version: 3.13.0 Identify at least one reason why no option to reduce the use or creation of this substance was implemented at your facility: Select the applicable reason or reasons ** There are no alternative processes and/or equipment identified, New equipment and/or processes were investigated, however, deemed unfeasible Explanation of the reasons why no option will be implemented   Rationale for why the listed options were chosen for implementation   General description of any actions undertaken by the owner and operator of the facility to reduce the use and creation of the toxic substance at the facility that are outside of the plan   License Number of the toxic substance reduction planner who made recommendations in the toxic substance reduction plan for this substance (format TSRPXXXX): * TSRP0123 Name of the toxic substance reduction planner who made recommendations in the toxic substance reduction plan for this substance (First Name Last Name) Daryl Chartrand License Number of the toxic substance reduction planner who has certified the toxic substance reduction plan for this substance (format TSRPXXXX): * TSRP0123 Name of the toxic substance reduction planner who has certified the toxic substance reduction plan for this substance (First Name Last Name) Daryl Chartrand What version of the plan is this summary based on?

Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • Disruptions or inefficiencies in our supply chain, logistics, or operations; • Changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Demand for our products and services; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; • Our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning system, S/4HANA; • Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts and any recessionary conditions; and • Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2023 under Item 1A, “Risk Factors.” FX +8.5% FX -0.4% Total Avient +8.1% Note: Regional Sales Percentages exclude impact of foreign exchange COLOR, ADDITIVES & INKS SEGMENT $487 $522 $89 $97 (in millions) (in millions) 10 + 7% (+8% excluding FX) + 9% (+11% excluding FX) 18.3% +40 bps *18.7% * * Adjusted EBITDA Margin % • Sales growth driven by winning new product specifications in consumer & packaging, strong underlying demand in healthcare and improving demand in building & construction • Favorable mix and raw material deflation contributed to EBITDA margin expansion SPECIALTY ENGINEERED MATERIALS SEGMENT $268 $295 $51 $57 (in millions) (in millions) 11 • Sales growth driven by restocking in healthcare & consumer end markets and strong underlying demand for composite applications used in building & construction, energy and defense end markets • Favorable mix contributed to EBITDA margin expansion + 10% (+10% excluding FX) + 12% (+13% excluding FX) 19.0% +40 bps *19.4% * * Adjusted EBITDA Margin % 2024 G U IDA N CE FY 2024 GUIDANCE Previous (Aug 6) Current Adjusted EPS $2.55 to $2.70 $2.63 to $2.67 Adjusted EBITDA $515 to $540 million $525 to $530 million Interest Expense $105 million $104 million Adjusted Effective Tax Rate 23% to 25% 23% to 25% Capital Expenditures & Investment in S/4 Hana ~$140 million ~$140 million 13 14 • Investor Day to be held December 4, 2024 at the NYSE, beginning at 10AM • The focus will be to do a deep dive on the Company’s strategy • Registration available at www.avient.com/investors 2024 AVIENT INVESTOR DAY AP P EN D IX 17 Performance Additives 15% Pigments TiO2 Dyestuffs Polyethylene 10%Nylon Polypropylene Styrenic Block Copolymer Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RAW MATERIAL BASKET SEGMENT DATA U.S. & Canada 41% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 19% 23%Industrial Building and END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) 19 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2023 REVENUE | $2 .0 B ILL ION 34% 37% 21% END MARKET REGION 20 34% 21% 15% Building & 1% Energy COLOR, ADDITIVES & INKS 2023 REVENUE | $1 .1 B ILL ION 52% 35% 21 6%Industrial 12% 10% Defense Building & END MARKET REGION SPECIALTY ENGINEERED MATERIALS 32% 26% Building & 6% 2% Defense 1% (18% of sales) 2023 AVIENT REGIONAL SALES 25% Building & (36% of sales)Transportation 22% Building & 12% 6% US & Canada (41% of sales) 59% 22% Building & LATAM (5% of sales) 22 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. Further, as a result of Avient's portfolio shift to a pure play specialty formulator, it has completed several acquisitions and divestitures which have resulted in a significant amount of intangible asset amortization.

CAR COMPONENT MANUFACTURER A C O U S T I C A N D T H E R M A L M A N A G E M E N T S Y S T E M S • High rPET content without loss of tenacity • High volume production • Color options • Offered a chain extender that supports stable spinning and maintains fiber tenacity to help achieve targeted rPET content • Provided technical support for production scale-up • Proposed different color concentrates suitable for application and polymer grade Cesa™ Fiber Additives – chain extenders for recycled polyester (rPET) KEY REQUIREMENTS WHY AVIENT?

The choice of the thermoplastic depends on the functional performance needed in the end-use application. In addition selection of the overmold TPE depends on the end-use application and environment. Spiral flow testing of developed products was conducted and is reported in Table 5 along with a conventional TPE and TPV of similar hardness.

Veškeré časy nebo termíny dodání uvedené Prodávajícím (včetně těch, které jsou uvedeny v potvrzení objednávky) jsou pouze odhady a nelze je chápat jako podmínky prodeje.

Does this application also require drilling, routing, fabrication, etc.?